# Docusign, Inc.: Form 10-Q for the period ended Oct 31, 2018

- Company: [Docusign, Inc.](/companies/docu.md) (CIK 1261333)
- Form: 10-Q
- Filed: 2018-12-07
- Accepted by EDGAR: Dec 7, 2018, 21:12 ET
- Period: 2018-10-31
- Accession: 0001261333-18-000027
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1261333/000126133318000027/q31910q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1261333/000126133318000027/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-10-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-08-01 to 2018-10-31 | $178.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2018-02-01 to 2018-10-31 | $501.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2018-08-01 to 2018-10-31 | $45.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2018-02-01 to 2018-10-31 | $139.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2018-08-01 to 2018-10-31 | $133.3m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2018-02-01 to 2018-10-31 | $361.5m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-08-01 to 2018-10-31 | $38.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2018-02-01 to 2018-10-31 | $143.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2018-08-01 to 2018-10-31 | −$58.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2018-02-01 to 2018-10-31 | −$363.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2018-08-01 to 2018-10-31 | $3.5m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2018-02-01 to 2018-10-31 | $3.7m | us-gaap:InterestExpense |
| Income tax | 3 months, 2018-08-01 to 2018-10-31 | −$5.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2018-02-01 to 2018-10-31 | −$3.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-08-01 to 2018-10-31 | −$52.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2018-02-01 to 2018-10-31 | −$360.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-08-01 to 2018-10-31 | −$0.31 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months, 2018-02-01 to 2018-10-31 | −$2.90 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months, 2018-02-01 to 2018-10-31 | $41.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2018-02-01 to 2018-10-31 | $19.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2018-10-31 | $1.09bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-10-31 | $1.27bn | us-gaap:AssetsCurrent |
| Total assets | at 2018-10-31 | $1.72bn | us-gaap:Assets |
| Current liabilities | at 2018-10-31 | $434.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-10-31 | $909.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-10-31 | $810.2m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1261333/000126133318000027/q31910q.htm

Filed Dec 7, 2018.
Source: SEC EDGAR, the filing index for accession 0001261333-18-000027. Last ingested by Listed: Nov 5, 2026, 13:21 ET. No prices; not investment advice.
